These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models. Brendza RP; Bales KR; Paul SM; Holtzman DM Mol Psychiatry; 2002; 7(2):132-5. PubMed ID: 11840304 [No Abstract] [Full Text] [Related]
3. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500 [TBL] [Abstract][Full Text] [Related]
4. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels. Pardon MC; Sarmad S; Rattray I; Bates TE; Scullion GA; Marsden CA; Barrett DA; Lowe J; Kendall DA Neurobiol Aging; 2009 Jul; 30(7):1099-113. PubMed ID: 18023506 [TBL] [Abstract][Full Text] [Related]
5. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice. Philipson O; Hammarström P; Nilsson KP; Portelius E; Olofsson T; Ingelsson M; Hyman BT; Blennow K; Lannfelt L; Kalimo H; Nilsson LN Neurobiol Aging; 2009 Sep; 30(9):1393-405. PubMed ID: 18192084 [TBL] [Abstract][Full Text] [Related]
6. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's theory makes a splash. Schnabel J Nature; 2009 May; 459(7245):310. PubMed ID: 19458681 [No Abstract] [Full Text] [Related]
9. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. DeMattos RB; Bales KR; Cummins DJ; Dodart JC; Paul SM; Holtzman DM Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8850-5. PubMed ID: 11438712 [TBL] [Abstract][Full Text] [Related]
10. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506 [TBL] [Abstract][Full Text] [Related]
11. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
12. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. DeMattos RB; Bales KR; Cummins DJ; Paul SM; Holtzman DM Science; 2002 Mar; 295(5563):2264-7. PubMed ID: 11910111 [TBL] [Abstract][Full Text] [Related]
13. A decade of modeling Alzheimer's disease in transgenic mice. McGowan E; Eriksen J; Hutton M Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017 [TBL] [Abstract][Full Text] [Related]
14. Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key? Walker LC; Bian F; Callahan MJ; Lipinski WJ; Durham RA; LeVine H Amino Acids; 2002; 23(1-3):87-93. PubMed ID: 12373522 [TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974 [TBL] [Abstract][Full Text] [Related]
16. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes. Rajendran L; Knobloch M; Geiger KD; Dienel S; Nitsch R; Simons K; Konietzko U Neurodegener Dis; 2007; 4(2-3):164-70. PubMed ID: 17596711 [TBL] [Abstract][Full Text] [Related]
17. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation. Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756 [TBL] [Abstract][Full Text] [Related]
18. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent. Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807 [TBL] [Abstract][Full Text] [Related]
19. [Significance of intracellular A beta in Alzheimer's disease]. Tabira T Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):175-80. PubMed ID: 12451689 [TBL] [Abstract][Full Text] [Related]
20. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]